Natera (NTRA) Competitors $161.88 +3.79 (+2.40%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NTRA vs. FMS, HIMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, and CONShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Natera vs. Fresenius Medical Care Hims & Hers Health Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Does the media refer more to FMS or NTRA? In the previous week, Natera had 7 more articles in the media than Fresenius Medical Care. MarketBeat recorded 11 mentions for Natera and 4 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.06 beat Natera's score of 0.97 indicating that Fresenius Medical Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in FMS or NTRA? 8.4% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend FMS or NTRA? Fresenius Medical Care presently has a consensus price target of $24.30, suggesting a potential upside of 6.53%. Natera has a consensus price target of $152.67, suggesting a potential downside of 5.69%. Given Fresenius Medical Care's higher possible upside, analysts clearly believe Fresenius Medical Care is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Natera 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, FMS or NTRA? Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$19.24B0.70$540.07M$1.2118.85Natera$1.53B13.95-$434.80M-$1.76-91.98 Is FMS or NTRA more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% Natera -14.01%-26.23%-14.27% Does the MarketBeat Community favor FMS or NTRA? Natera received 58 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.82% of users gave Natera an outperform vote while only 54.68% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42154.68% Underperform Votes34945.32% NateraOutperform Votes47968.82% Underperform Votes21731.18% Which has more volatility & risk, FMS or NTRA? Fresenius Medical Care has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. SummaryFresenius Medical Care and Natera tied by winning 9 of the 18 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.37B$2.94B$5.02B$9.08BDividend YieldN/A15.59%4.87%4.18%P/E Ratio-91.9816.02135.2017.17Price / Sales13.95284.461,120.31115.67Price / CashN/A472.1140.5837.88Price / Book25.415.194.754.78Net Income-$434.80M-$32.86M$118.50M$225.60M7 Day Performance-2.80%-2.98%-1.83%-1.26%1 Month Performance-3.57%4.03%12.27%4.37%1 Year Performance182.61%15.76%31.72%18.73% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera2.0809 of 5 stars$161.88+2.4%$152.67-5.7%+182.6%$21.37B$1.53B-91.983,293Positive NewsGap DownHigh Trading VolumeFMSFresenius Medical Care3.491 of 5 stars$23.99+1.4%$24.30+1.3%+11.4%$14.08B$19.24B19.791,358News CoveragePositive NewsHIMSHims & Hers Health3.3847 of 5 stars$30.91+3.0%$21.43-30.7%+214.3%$6.56B$872M70.251,046Analyst ForecastInsider TradeNews CoverageGHGuardant Health4.1067 of 5 stars$35.14+1.1%$40.60+15.5%+25.6%$4.34B$692.26M-8.201,779OPCHOption Care Health4.8665 of 5 stars$23.45-0.2%$30.14+28.5%-29.9%$3.99B$4.78B19.747,802Positive NewsSHCSotera Health3.5846 of 5 stars$13.07-0.6%$16.08+23.1%-20.0%$3.70B$1.05B52.603,000Positive NewsVCYTVeracyte4.0276 of 5 stars$43.44+0.5%$41.13-5.3%+49.0%$3.37B$361.05M-288.13790Positive NewsBTSGBrightSpring Health Services2.3113 of 5 stars$18.88+1.7%$18.50-2.0%N/A$3.29B$10.59B-71.3835,000Analyst ForecastPositive NewsLFSTLifeStance Health Group1.7047 of 5 stars$7.80+8.8%$8.70+11.5%-0.3%$2.98B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2475 of 5 stars$22.01+8.1%$36.56+66.1%-33.8%$2.80B$2.74B-42.4213,500CONConcentra Group Holdings ParentN/A$21.51+4.9%$28.50+32.5%N/A$2.74B$1.88B0.0011,000 Related Companies and Tools Related Companies FMS Competitors HIMS Competitors GH Competitors OPCH Competitors SHC Competitors VCYT Competitors BTSG Competitors LFST Competitors SGRY Competitors CON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NTRA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
